Blog
Month: April 2022

New FDA guidance: cell therapies and patient identifiers

Blog

When the US Food and Drug Administration (FDA) recently made two draft guidance documents for the cell and gene therapies available for comment, the Vineti…

sedApta Group and Vineti partner to develop integrated digital supply chain and manufacturing solution for cell and gene therapies

Blog

The sedApta Group, a global software provider specialized in innovative IT solutions for digital Supply Chain and Smart Manufacturing, and Vineti, the provider of the…

Cell and gene therapies: the necessity of a purpose-built platform

Blog

Given the wide array of CRMs and other digital systems already serving healthcare and biopharma, that reality might sound like overkill. But after more than…